Incidence, clinical characteristics, risk factors and outcomes of meningoencephalitis in patients with COVID-19


Por: Fragiel, M, Miro, O, Llorens, P, Jimenez, S, Salmeron, P, Burillo-Putze, G, Martin, A, Martin-Sanchez, F, Lamberechts, E, Jacob, J, Alquezar-Arbe, A, Llopis-Roca, F, Garcia, J, Lopez, R, Vera, M, Lucas-Imbernon, F, Martinez, F, Juarez, R, Rodriguez, M, Bautista, B, Valdes, A, Nicolas, J, Amez, J, Porta-Etessam, J, Calvo, E, del Castillo, J and Spanish Investigators Emergency Si

Publicada: 1 ago 2021 Ahead of Print: 1 mar 2021
Resumen:
We investigated the incidence, clinical characteristics, risk factors, and outcome of meningoencephalitis (ME) in patients with COVID-19 attending emergency departments (ED), before hospitalization. We retrospectively reviewed all COVID patients diagnosed with ME in 61 Spanish EDs (20% of Spanish EDs, COVID-ME) during the COVID pandemic. We formed two control groups: non-COVID patients with ME (non-COVID-ME) and COVID patients without ME (COVID-non-ME). Unadjusted comparisons between cases and controls were performed regarding 57 baseline and clinical characteristics and 4 outcomes. Cerebrospinal fluid (CSF) biochemical and serologic findings of COVID-ME and non-COVID-ME were also investigated. We identified 29 ME in 71,904 patients with COVID-19 attending EDs (0.40 parts per thousand, 95%CI=0.27-0.58). This incidence was higher than that observed in non-COVID patients (150/1,358,134, 0.11 parts per thousand, 95%CI=0.09-0.13; OR=3.65, 95%CI=2.45-5.44). With respect to non-COVID-ME, COVID-ME more frequently had dyspnea and chest X-ray abnormalities, and neck stiffness was less frequent (OR=0.3, 95%CI=0.1-0.9). In 69.0% of COVID-ME, CSF cells were predominantly lymphocytes, and SARS-CoV-2 antigen was detected by RT-PCR in 1 patient. The clinical characteristics associated with a higher risk of presenting ME in COVID patients were vomiting (OR=3.7, 95%CI=1.4-10.2), headache (OR=24.7, 95%CI=10.2-60.1), and altered mental status (OR=12.9, 95%CI=6.6-25.0). COVID-ME patients had a higher in-hospital mortality than non-COVID-ME patients (OR=2.26; 95%CI=1.04-4.48), and a higher need for hospitalization (OR=8.02; 95%CI=1.19-66.7) and intensive care admission (OR=5.89; 95%CI=3.12-11.14) than COVID-non-ME patients. ME is an unusual form of COVID presentation (<0.5 parts per thousand cases), but is more than 4-fold more frequent than in non-COVID patients attending the ED. As the majority of these MEs had lymphocytic predominance and in one patient SARS-CoV-2 antigen was detected in CSF, SARS-CoV-2 could be the cause of most of the cases observed. COVID-ME patients had a higher unadjusted in-hospital mortality than non-COVID-ME patients.

Filiaciones:
Fragiel, M:
 Univ Complutense, IDISSC, Hosp Clin San Carlos, Emergency Dept, Prof Martin Lagos S-N, Marid 28040, Spain

Miro, O:
 Univ Barcelona, IDIBAPS, Hosp Clin, Emergency Dept, Barcelona, Catalonia, Spain

:
 Univ Miguel Hernandez, Hosp Gen Alicante, Emergency Dept, Alicante, Spain

Jimenez, S:
 Univ Barcelona, IDIBAPS, Hosp Clin, Emergency Dept, Barcelona, Catalonia, Spain

Salmeron, P:
 Hosp Reina Sofia, Emergency Dept, Murcia, Spain

Burillo-Putze, G:
 Hosp Univ Canarias, Emergency Dept, Tenerife, Spain

Martin, A:
 Hosp Severo Ochoa, Emergency Dept, Madrid, Spain

Martin-Sanchez, F:
 Univ Complutense, IDISSC, Hosp Clin San Carlos, Emergency Dept, Prof Martin Lagos S-N, Marid 28040, Spain

Lamberechts, E:
 Univ Complutense, IDISSC, Hosp Clin San Carlos, Emergency Dept, Prof Martin Lagos S-N, Marid 28040, Spain

Jacob, J:
 Hosp Univ Bellvitge, Emergency Dept, Barcelona, Catalonia, Spain

Alquezar-Arbe, A:
 Hosp Santa Creu & Sant Pau, Emergency Dept, Barcelona, Catalonia, Spain

Llopis-Roca, F:
 Hosp Univ Bellvitge, Emergency Dept, Barcelona, Catalonia, Spain

Garcia, J:
 Hosp Valle Los Pedroches Pozoblanco Cordoba, Emergency Dept, Pozoblanco, Spain

Lopez, R:
 Complejo Hosp Univ A Coruna, La Coruna, Spain

Vera, M:
 Complejo Hosp Univ Vigo, Hosp Alvaro Cunqueiro, Vigo, Spain

Lucas-Imbernon, F:
 Hosp Univ Gen Albacete, Albacete, Spain

Martinez, F:
 Hosp Virgen Luz Cuenca, Cuenca, Spain

Juarez, R:
 Hosp Nuestra Senora Prado Talavera Reina Toledo, Emergency Dept, Talavera De La Reina, Spain

Rodriguez, M:
 Hosp Univ Canarias, Emergency Dept, Tenerife, Spain

Bautista, B:
 Hosp Univ Cent Asturias, Oviedo, Spain

Valdes, A:
 Hosp Univ Cabuenes Gijon, Gijon, Spain

Nicolas, J:
 Hosp Reina Sofia, Emergency Dept, Murcia, Spain

 Univ Lozano Blesa, Hosp Clin, Zaragoza, Spain

Amez, J:
 Univ Lozano Blesa, Hosp Clin, Zaragoza, Spain

Porta-Etessam, J:
 Hosp Clin San Carlos, Neurol Dept, Madrid, Spain

Calvo, E:
 Univ Complutense, IDISSC, Hosp Clin San Carlos, Internal Med Dept, Madrid, Spain

del Castillo, J:
 Univ Complutense, IDISSC, Hosp Clin San Carlos, Emergency Dept, Prof Martin Lagos S-N, Marid 28040, Spain
ISSN: 09349723





EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Editorial
SPRINGER, 233 SPRING ST, NEW YORK, NY 10013 USA, Alemania
Tipo de documento: Article
Volumen: 40 Número: 8
Páginas: 1645-1656
WOS Id: 000626340300001
ID de PubMed: 33686558
imagen Green Published, Bronze

MÉTRICAS